MapLight Therapeutics, Inc.

MapLight Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative therapies for neurological and psychiatric disorders. The company utilizes its proprietary drug discovery platform to identify and advance novel small molecule compounds that target specific brain circuits implicated in these conditions. By modulating these circuits, MapLight aims to address the underlying causes of diseases such as schizophrenia, autism spectrum disorder, and other cognitive impairments. Their research and development efforts are geared towards creating transformative treatments that improve the lives of patients suffering from these debilitating illnesses. MapLight Therapeutics is committed to advancing the understanding of brain circuitry and translating this knowledge into effective therapeutic solutions within the pharmaceutical sector.